Nd Edition Governing Health

FDA approves Three Palm imaging product

December 31, 2007 on 8:45 pm | In Uncategorized | Comments Off Three Palm Software LLC said Monday it received clearance from the U.S. Food and Drug Administration for its breast imaging workstation.

Accentia’s loss widens to $76 million in ‘07

December 31, 2007 on 8:13 pm | In Uncategorized | Comments Off Accentia Biopharmaceuticals Inc., which has unit operations in St. Louis, reported that its net loss widened to $76 million for the fiscal year ended Sept. 30, compared to a net loss of $43.4 million last fiscal year. (ABPI)

U.K. pulls Glaxo into Iraq fraud probe

December 31, 2007 on 6:10 pm | In Uncategorized | Comments Off The United Kingdom's Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have been paid to Iraqi officials in the government of Saddam Hussein. (GSK)

Cephalon seeks OK for non-Hodgkin’s lymphoma treatment

December 31, 2007 on 4:47 pm | In Uncategorized | Comments Off Cephalon Inc. submitted a new drug application with the Food and Drug Administration Monday seeking marketing approval for its experimental cancer drug Treanda. (CEPH)

UK investigating GlaxoSmithKline, AstraZeneca in oil-for-food bribe probe

December 31, 2007 on 4:29 pm | In Uncategorized | Comments Off The United Kingdom's Serious Fraud Office has requested documents from two pharmaceutical companies with strong ties to the Philadelphia region, GlaxoSmithKline and AstraZeneca, as part of an investigation into the United Nations' oil-for-food program. (GSK) (AZN)